Boston Advisors’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$3.09M Buy
346,129
+6,297
+2% +$55K 0.16% 171
2019
Q2
$2.91M Buy
339,832
+4,186
+1% +$33.1K 0.16% 174
2019
Q1
$2.55M Sell
335,646
-2,617
-0.8% -$21K 0.13% 196
2018
Q4
$2.8M Buy
338,263
+8,316
+3% +$79.6K 0.16% 161
2018
Q3
$3.27M Hold
329,947
0.14% 228
2018
Q2
$3.23M Buy
329,947
+2,580
+0.8% +$25.3K 0.08% 236
2018
Q1
$3.04M Buy
327,367
+61,987
+23% +$590K 0.08% 239
2017
Q4
$2.52M Buy
265,380
+36,244
+16% +$346K 0.05% 271
2017
Q3
$2.37M Buy
229,136
+5,907
+3% +$54.5K 0.05% 273
2017
Q2
$1.85M Buy
223,229
+45,480
+26% +$341K 0.04% 305
2017
Q1
$1.28M Sell
177,749
-42,464
-19% -$308K 0.03% 324
2016
Q4
$1.57M Buy
220,213
+4,019
+2% +$28K 0.04% 315
2016
Q3
$1.57M Buy
216,194
+1,961
+0.9% +$12.5K 0.04% 301
2016
Q2
$1.25M Buy
214,233
+1,263
+0.6% +$8.37K 0.03% 318
2016
Q1
$1.35M Buy
212,970
+19,218
+10% +$103K 0.03% 291
2015
Q4
$1.24M Buy
193,752
+4,830
+3% +$30.2K 0.03% 304
2015
Q3
$1.1M Sell
188,922
-1,340
-0.7% -$9.94K 0.04% 367
2015
Q2
$1.66M Buy
190,262
+8,838
+5% +$74.2K 0.07% 228
2015
Q1
$1.45M Buy
181,424
+4,738
+3% +$35.4K 0.06% 244
2014
Q4
$1.37M Sell
176,686
-311
-0.2% -$2.27K 0.06% 233
2014
Q3
$1.15M Buy
176,997
+63,874
+56% +$493K 0.05% 266
2014
Q2
$951K Buy
+113,123
New +$877K 0.04% 283
2013
Q3
Sell
-30,392
Closed -$134K 586
2013
Q2
$134K Buy
+30,392
New +$135K 0.01% 549

Other funds holding SEM

Boston Advisors's SEM Position: Q3 2019 in Review

Boston Advisors increased its Select Medical (SEM) stake by 1.9% in Q3 2019, buying an estimated $55K and bringing the position to 346,129 shares worth $3.09M. The position accounts for 0.16% of the portfolio, ranked #171.

Boston Advisors first reported a position in SEM in Q2 2013 and has held it in 23 quarters since. The position peaked at $3.27M in Q3 2018. 187 funds tracked by Wall St. Rank hold SEM as of Q3 2019.

  • Boston Advisors held 346,129 shares of Select Medical worth $3.09M as of Q3 2019.
  • Boston Advisors bought 6,297 Select Medical shares in Q3 2019, an estimated $55K.
  • Select Medical made up 0.16% of Boston Advisors's portfolio in Q3 2019, its #171 holding.
  • Boston Advisors first reported a position in Select Medical in Q2 2013 and has held it in 23 quarters since.
  • Boston Advisors's Select Medical position peaked at $3.27M in Q3 2018.
  • 187 funds tracked by Wall St. Rank held Select Medical as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.